Welcome to our dedicated page for Cardinal Health news (Ticker: CAH), a resource for investors and traders seeking the latest updates and insights on Cardinal Health stock.
Cardinal Health, Inc. (NYSE: CAH) generates a steady flow of news as a major participant in pharmaceutical distribution, medical products manufacturing and distribution, home-health services, and specialty healthcare support. This CAH news page aggregates company press releases and third-party coverage so readers can follow how Cardinal Health’s strategy, operations, and capital decisions evolve over time.
Recent news highlights include updates on financial performance and outlook, such as first-quarter fiscal 2026 results reported via Form 8-K and subsequent press releases, where Cardinal Health discussed revenue growth, segment profit trends, and revised non-GAAP earnings guidance. The company also issues announcements about upcoming earnings releases and webcasts, providing dates and times for quarterly and annual results discussions.
Cardinal Health’s news flow also covers strategic initiatives and acquisitions. For example, the company has reported on its plan and subsequent completion of the acquisition of Solaris Health, described as a leading urology management services organization that adds scale to The Specialty Alliance. Other updates discuss growth in Specialty revenues, expansion of MSO platforms, and the role of BioPharma Solutions and Sonexus™ Access and Patient Support in serving manufacturer partners and patients.
Operational and infrastructure developments are another key news theme. Cardinal Health has announced a new flagship Pharmaceutical and Specialty Solutions forward distribution center in Indianapolis, Indiana, a Consumer Health Logistics Center in Ohio, and new and planned at-Home Solutions distribution centers in Texas and California, all emphasizing automation and technology to support distribution and logistics.
Investors and observers can also find capital markets and governance updates in Cardinal Health’s news, including public offerings of notes to fund acquisitions, quarterly dividend declarations approved by the Board of Directors, and information related to annual shareholder meetings. Bookmark this page to review Cardinal Health (CAH) news across earnings, acquisitions, infrastructure investments, and governance developments in one place.
Children's Hospital Association (CHA), Cardinal Health (NYSE: CAH), and Zero Suicide Institute (ZSI) commemorate World Suicide Prevention Day by highlighting the success of their Preventing Youth Suicide Collaborative. Since 2022, 30 children's hospitals have screened nearly 320,000 children, with 15% requiring mental health support. ZSI developed a Zero Suicide Toolkit for Children's Hospitals to aid implementation strategies.
Suicide is now the second leading cause of death among 10- to 24-year-olds, according to the CDC. The collaborative aims to provide early detection, better screening, and timely intervention. Participating hospitals, like Phoenix Children's and Valley Children's Healthcare, have implemented comprehensive screening processes.
CHA urges Congress to pass the EARLY Minds Act and the Helping Kids Cope Act to prioritize youth mental health and improve care availability.
Cardinal Health (NYSE: CAH) has officially opened a new distribution center in Greenville, South Carolina, dedicated to its at-Home Solutions business. This 350,000 square foot facility, the largest for the at-Home Solutions division, is expected to create approximately 200 jobs over time. The center will support the growing home healthcare industry, projected to reach $176.3 billion by 2032.
The facility will utilize advanced automation, AI, and robotics to ship nearly 8,000 packages daily directly to patients' homes. These packages include critical medical supplies such as diabetic equipment, incontinence and ostomy supplies, and enteral nutrition products. This expansion aligns with the increasing demand for home healthcare services, driven by America's aging population and the rising prevalence of chronic conditions.
Cardinal Health (NYSE: CAH) has announced plans to open a new 249,000 square foot distribution center in Walton Hills, Ohio, expanding its medical product distribution footprint in Northeast Ohio. The facility, set to be fully operational by spring 2025, will be over 30% larger than the Solon, Ohio location it replaces. It will feature advanced technology and automation to improve service quality, enhance employee work experiences, and increase storage capacity.
This expansion is part of Cardinal Health's broader strategy to improve infrastructure, warehouse operations, and supply chain resiliency. The company has recently opened new distribution centers in Central Ohio and Montgomery, N.Y., with another facility opening soon in the Boston area. These investments demonstrate Cardinal Health's commitment to meeting growing customer needs and strengthening its U.S. Medical Products and Distribution business.
Cardinal Health (NYSE: CAH) has announced that its Board of Directors has approved a quarterly dividend of $0.5056 per share. This dividend will be paid out of the company's capital surplus. Shareholders who are on record at the close of business on October 1, 2024, will receive the dividend payment on October 15, 2024. This announcement demonstrates Cardinal Health's commitment to returning value to its shareholders through regular dividend payments.
Cardinal Health (NYSE: CAH) reported strong Q4 and FY2024 results, raising its FY2025 guidance. Q4 revenue increased 12% to $59.9 billion, with non-GAAP operating earnings up 14% to $605 million. Non-GAAP diluted EPS rose 29% to $1.84. For FY2024, revenue grew 11% to $226.8 billion, non-GAAP operating earnings increased 16% to $2.4 billion, and non-GAAP diluted EPS climbed 29% to $7.53.
The company achieved record operating cash flow of $3.8 billion and adjusted free cash flow of $3.9 billion. Cardinal Health raised its FY2025 non-GAAP EPS guidance to $7.55-$7.70, up from at least $7.50 previously. The Pharmaceutical and Specialty Solutions segment saw 13% revenue growth in Q4, while Global Medical Products and Distribution segment profit significantly improved.
Cardinal Health (NYSE: CAH) has announced that it will release its fourth-quarter and year-end financial results for fiscal year 2024 on August 14, 2024, before the opening of trading on the New York Stock Exchange. The company will host a webcast discussion of the results starting at 8:30 a.m. Eastern.
Investors and interested parties can access the webcast and accompanying slide presentation through Cardinal Health's Investor Relations page. No access code is required for participation. The presentation slides and a replay of the webcast will remain available on the Investor Relations page for 12 months following the event.
Cardinal Health (CAH) has announced an increase in its quarterly dividend to $0.5056 per share, payable on July 15, 2024, to shareholders of record as of July 1, 2024.
Cardinal Health reported third quarter fiscal year 2024 revenues of $54.9 billion, a 9% increase from the previous year. GAAP operating earnings were $367 million, with GAAP diluted EPS at $1.05. Non-GAAP operating earnings increased 10% to $666 million, and non-GAAP diluted EPS rose 20% to $2.08. The company raised its fiscal year 2024 non-GAAP EPS guidance to $7.30 to $7.40 and provided preliminary guidance for fiscal year 2025 of at least $7.50.
Summary not available.
Summary not available.